Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Pharmala Biotech Holdings Inc
C.MDMA
Alternate Symbol(s):
MDXXF
PharmAla Biotech Holdings Inc. is a Canada-based biotechnology company. The Company is focused on the development, manufacture and sales of methylenedioxy methamphetamine (MDMA) and methylenedioxy phenethylamines (MDXX) class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The Company has three primary business lines...
: the manufacture of MDMA and MDXX class molecules for sale to clinical researchers in both the commercial and academic sphere, the research and development of novel MDXX class compounds which offer unique benefits above and beyond known substances, and the development of novel delivery mechanisms for MDMA and MDXX class compounds. Its research and development unit has completed proof-of-concept research into several IP families, including ALA-002, its lead drug candidate. It works with laboratories across Canada to develop novel processes for the supply of LaNeo MDMA and other MDXX substances.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:MDMA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(22)
•••
1991nightmaress
X
View Profile
View Bullboard History
Post by
1991nightmaress
on Aug 12, 2024 1:27pm
Today
I think today's action is a little fear mongering , trying to use the fda against us , we all would of love the wind in our sails but was not to be .. o well fire up the engine
(174)
•••
inviolablspirit
X
View Profile
View Bullboard History
Comment by
inviolablspirit
on Aug 12, 2024 1:18pm
RE:The latest
Thanks for the video post. I'm glad to see this video backs the information in my posts. It gives me confidence that my understanding of this company and the direction they are going
...more
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(22)
•••
1991nightmaress
X
View Profile
View Bullboard History
Post by
1991nightmaress
on Aug 12, 2024 11:18am
The latest
Going forward.. https://m.youtube.com/watch?v=S3ug1fWoxd4
(174)
•••
inviolablspirit
X
View Profile
View Bullboard History
Comment by
inviolablspirit
on Aug 12, 2024 10:48am
RE:RE:Pharmala's US patent granted for ALA-002
Sorry my mistake in my posting it should say "US approved patent now in hand"
(174)
•••
inviolablspirit
X
View Profile
View Bullboard History
Comment by
inviolablspirit
on Aug 12, 2024 10:30am
RE:Pharmala's US patent granted for ALA-002
The Market cap of this company doesn't make much sense at these prices with their IP and business proceeding in Australia and Canada which hasn't changed when it traded at over 30 cents. Nick
...more
(174)
•••
inviolablspirit
X
View Profile
View Bullboard History
Post by
inviolablspirit
on Aug 11, 2024 7:32pm
Pharmala's US patent granted for ALA-002
Is it just me or does it seem like Pharmala's US patent being granted for ALA-002 is not getting the attention and fan fair that it deserves. That news alone should be raising the
...more
(174)
•••
inviolablspirit
X
View Profile
View Bullboard History
Post by
inviolablspirit
on Aug 10, 2024 2:07pm
FDA Decision
I'm not surprised that FDA is requesting more data and another phase 3 trial from Lykos, through they certainly could have collected more data with an approval and added restrictions too.
...more
(157)
•••
Chefboy69
X
View Profile
View Bullboard History
Comment by
Chefboy69
on Aug 10, 2024 5:31am
RE:Junior Markets
here read this your are exactly correct Nuvei CEO Phil Fayer on the perils of running a public tech company – and why he’s taking it private
(174)
•••
inviolablspirit
X
View Profile
View Bullboard History
Post by
inviolablspirit
on Aug 07, 2024 4:39pm
Junior Markets
Man, the junior market continues to get the cr@p kicked out of it and it never had a recovery. The short selling pressure by institutions and others is killing these exchanges and the regulators
...more
(174)
•••
inviolablspirit
X
View Profile
View Bullboard History
Comment by
inviolablspirit
on Aug 07, 2024 4:06pm
RE:0.095 cents!!
Pharmala's business is outside the US market so technically it really shouldn't matter what the FDA decision is. What matters is the direction other countries are going and if Pharmala
...more
(41)
•••
polygraph46
X
View Profile
View Bullboard History
Post by
polygraph46
on Aug 02, 2024 8:07pm
0.095 cents!!
Yikes. If we don't get a green light from FDA, next couple of weeks, it will be a long time fore we are back in the 0.19 cent range, here's hoping ......pg
(22)
•••
1991nightmaress
X
View Profile
View Bullboard History
Post by
1991nightmaress
on Jun 24, 2024 6:44pm
Good read
https://www.lucid.news/lykos-confident-working-with-fda-mdma-approval/
(17)
•••
Jimmycootes
X
View Profile
View Bullboard History
Post by
Jimmycootes
on Jun 24, 2024 4:17pm
Nice close
Closing at 13 is a new high since the shares tumbled in price. If we would of had our regular daily volume the SP would have hit 15 cents. It's a slow grind, but soon enough we'll be back
...more
(17)
•••
Jimmycootes
X
View Profile
View Bullboard History
Post by
Jimmycootes
on Jun 13, 2024 3:55pm
Over 2.2 million
Over 2.2 million shares traded at an average 13.6 cents. Great day! Tomorrow should be nice.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >